Log in

Relevant bibliographies by topics / Oral vaccines / Books

To see the other types of publications on this topic, follow the link: Oral vaccines.

Books on the topic 'Oral vaccines'

Author: Grafiati

Published: 4 June 2021

Last updated: 7 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 32 books for your research on the topic 'Oral vaccines.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Geneva), WHO Consultation on Oral Immunization of Dogs Against Rabies (5th 1994. Report of the 5th WHO Consultation on Oral Immunization of Dogs Against Rabies, Geneva, 20-22 June, 1994. Geneva: World Health Organization, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

WHO Consultation on Oral Immunization of Dogs Against Rabies (4th 1993 Geneva). Report of the 4th WHO Consultation on Oral Immunization of Dogs Against Rabies, Geneva, 14-15 June, 1993. Geneva: World Health Organization, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

World Health Organization (WHO). Second WHO consultation on oral immunization of dogs against rabies, Geneva, 6th July, 1990. Geneva: World Helath Organization, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Koprowski, Hilary. Vaccines--Advances in plant and microbial biotechnology infectious immunity and cancer therapy: Celebration of the 50th anniversary of the first vaccination of a Polish child against polio using Dr. Hilary Koprowski's oral polio vaccine, Warsaw University of Life Sciences-SGGW, Warsaw, Poland, November 28-29, 2008. Warsaw: Warsaw University of Life Sciences-SGGW, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

World Health Organization (WHO). Third WHO consultation on oral immunization of dogs against rabies, Geneva, 21-22 July, 1992. Geneva: World Helath Organization, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

World Health Organization (WHO). Report of WHO consultation on oral immunization of dogs against rabies, Geneva, 26-27 February, 1988. Geneva: World Helath Organization, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Organization, World Health. WHO/APHIS consultation on baits and baiting delivery systems for oral immunization of wildlife againstrabies, Colorado State University, Fort Collins, Colorado, 10-12 July, 1990. Geneva: World Health Organization, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

WHO Consultation on Requirements and Criteria for Field Trials on Oral Rabies Vaccination of Dogs and Wild Carnivores (1989 Geneva). Report of WHO Consultation on Requirements and Criteria for Field Trials on Oral Rabies Vaccination of Dogs and Wild Carnivores, held 1-2 March, 1989, in Geneva. Geneva: World Health Organization, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Workshop on Development of a Polio Antiviral and Its Potential Role in Global Poliomyelitis Eradication (2005 Washington, D.C.). Exploring the role of antiviral drugs in the eradication of polio: Workshop report. Washington, D.C: National Academies Press, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Coulson, Nicholas Michael. Expression of the protective antigen of bacillus anthracis in attenuated salmonella: A potential oral anthrax vaccine. [s.l.]: typescript, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

World Health Organization (WHO). Report of WHO informal consultation on oral/conjunctival brucellosis strain 2 vaccine, Geneva, 2-4 April, 1990. Geneva: World health Organization, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Organization, World Health. Report of WHO informal meeting on oral/conjunctival brucellosis strain 2 vaccine, Nouzilly, France, 8-9February, 1989. Geneva: World health Organization, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

World Health Organization (WHO). Report of WHO working group meeting on oral/conjunctival brucellosis strain 2 vaccine, Rome, 2-4 October, 1991. Geneva: World Health Organization, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

T, O'Hagan Derek, ed. Novel delivery systems for oral vaccines. Boca Raton: CRC Press, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

Wong, George Kaon. Development of novel oral enteric-coated aquaculture vibrio vaccines. 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Piganelli, Jon D. Development of enteric protected vaccines for aquaculture. 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Zhang, Jia Ai. Fish oral antigen delivery system development and optimization. 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

New Strategies For Oral Immunization (Current Topics in Microbiology & Immunology). Springer, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Mestecky, Jiri, and Jerry R. McGhee. New Strategies for Oral Immunization: International Symposium at the University of Alabama at Birmingham and Molecular Engineering Associates, Inc. ... Topics in Microbiology and Immunology). Brand: Springer, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

Sparadbrow, P. H., and P. H. Spradbrow. Newcastle Disease in Village Chickens: Control with Thermostable Oral Vaccines (Aciar Proceedings). Hyperion Books, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

New strategies for oral immunization: International symposium at the University of Alabama at Birmingham and Molecular Engineering Associates, Inc., Birmingham, AL, USA, March 21-22, 1988. Berlin: Springer-Verlag, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Majid, Adrian, and Bruce L. Gilliam. Future Antiretrovirals, Immune-Based Strategies, and Therapeutic Vaccines. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0023.

Full text

Abstract:

Highly active antiretroviral therapy remains the mainstay of treatment for patients chronically infected with HIV. Novel drugs, both within existing classes and new ones, are in various stages of development and testing. New medications within existing classes of antiretroviral agents are in clinical trials and will likely offer activity against resistant HIV-1 strains and provide alternatives for combination pill therapy. Novel therapeutics including oral attachment inhibitors and monoclonal antibody treatments continue to show efficacy against HIV-1 and progress in clinical trials. Tenofovir alafenamide is a prodrug that produces higher intracellular levels of tenofovir diphosphate with likely less renal and bone toxicity. Among traditional classes of HIV treatment, both doravirine (a non-nucleoside reverse transcriptase inhibitor) and cabotegravir (an integrase strand inhibitor) are newer agents with activity against resistant virus. Maturation inhibitors are a new class of treatment that block protease cleavage, leading to the release of an immature virion.

APA, Harvard, Vancouver, ISO, and other styles

23

(Editor), Benjamin P. Lewis, ed. International Workshop on Poliovirus Attenuation: Molecular Mechanisms and Practical Aspects : Proceedings of a Workshop Held at Bethesda, Mc, USA D (Developments in Biologicals). S Karger Pub, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

B, Spradbrow P., ed. Newcastle disease in village chickens: Control with thermostable oral vaccines : proceedings of an international workshop held in Kuala Lumpur, Malaysia, 6-10 October 1991. Canberra: Australian Centre for International Agricultural Research, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

H, Kiyono, Ogra Pearay L, and McGhee Jerry R, eds. Mucosal vaccines. San Diego: Academic Press, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Memória da poliomielite: Acervo de depoimentos orais. Rio de Janeiro: Casa de Oswaldo Cruz, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

Memória da poliomielite: Acervo de depoimentos orais. Rio de Janeiro: Casa de Oswaldo Cruz, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

Rider, Jennifer R., Paul Brennan, and Pagona Lagiou. Oral and Pharyngeal Cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780190676827.003.0007.

Full text

Abstract:

This chapter covers cancer of the oral cavity and the oropharynx, which includes the base of the tongue, soft palate, tonsils, and back and side walls of the throat. Many important risk factors for oral and oropharyngeal cancer have been identified, and in 2007 the World Health Organization determined there was sufficient evidence to include human papilloma virus (HPV) type 16 as a cause of these cancers. Tobacco and alcohol remain important modifiable risk factors, but the increasing incidence of HPV-associated tumors is now evident. While these tumors are more amenable to treatment than HPV-negative tumors, they are still a source of considerable morbidity and mortality. Moreover, the lack of a precursor lesion and limited data on efficacy of the HPV vaccine in preventing oral HPV infection are barriers to primary and secondary prevention efforts. Dietary patterns high in fruits and vegetables and low in meats may confer some protection.

APA, Harvard, Vancouver, ISO, and other styles

29

Jex, Aaron R., Rachel M. Chalmers, Huw V. Smith, Giovanni Widmer, Vincent McDonald, and Robin B. Gasser. Cryptosporidiosis. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780198570028.003.0053.

Full text

Abstract:

Cryptosporidium species represent a genus of parasitic protozoa (Apicomplexa) that are transmitted via the faecal-oral route and commonly infect the epithelial tissues of the gastric or intestinal (or sometimes the respiratory) tract of many vertebrates, including humans. Infection occurs following the ingestion of viable and resistant oocysts, through direct host-to-host contact or in contaminated food, drinking or recreational water. Infection can be transmitted via anthroponotic (human-to-human, human-to-animal) or zoonotic (animal-to-human or animal-to-animal) pathways, depending upon the species of Cryptosporidium. Although infection can be asymptomatic, common symptoms of disease (cryptosporidiosis) include diarrhoea, colic (abdominal pain), nausea or vomiting, dehydration and/or fever. In humans, cryptosporidial infection in immunocompetent patients is usually short-lived (days to weeks) and eliminated following the stimulation of an effective immune response. However, infection in immunodeficient individuals (e.g., those with HIV/AIDS) can be chronic and fatal (in the absence of immunotherapy), as there are few effective anti-cryptosporidial drugs and no vaccines available. The present chapter provides an account of the history, taxonomy and biology, genomics and genetics of Cryptosporidium, the epidemiology, pathogenesis, treatment and control of cryptosporidiosis and the advances in tools for the identification and characterisation of Cryptosporidium species and the diagnosis of cryptosporidiosis.

APA, Harvard, Vancouver, ISO, and other styles

30

Renne, Elisha P. Polio vaccination, political authority and the Nigerian state. Manchester University Press, 2017. http://dx.doi.org/10.7228/manchester/9781526110886.003.0012.

Full text

Abstract:

Vaccination campaigns rely on the political authority of the state to carry out public health programs for the benefit of its citizens. In sub-Saharan Africa where vaccination programs were introduced by health officials during colonial rule, subsequent postcolonial programs, such as interventions which focus on a single disease and are supported mainly by western international NGOs, may be viewed with suspicion by some. Rather than strengthening state control of its citizens, vaccination campaigns such as the Global Polio Eradication Initiative as implemented in northern Nigeria, may undermine state authority and control. With its initial focus on polio vaccination rather than on childhood diseases which parents considered more life-threatening, the initiative highlighted the federal government’s failure to provide basic primary health care. That the GPEI was funded by western international NGOs also led some Muslim parents, religious leaders, and medical professionals to question the safety of the oral polio vaccine and to refuse vaccination for their children. However, in 2013 their actions have been tempered by programs providing monetary awards to state governments and foodstuffs to cooperating mothers and in September 2015, WHO announced the interruption of wild poliovirus in Nigeria.

APA, Harvard, Vancouver, ISO, and other styles

31

Lincei, Accademia nazionale dei, and Consiglio nazionale delle ricerche (Italy), eds. Origin of HIV and emerging persistent viruses: Tavola rotonda nell'ambito della conferenza annuale della ricerca : Roma 28-29 settembre 2001. Roma: Accademia nazionale dei Lincei, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

(US), National Research Council. Exploring the Role of Antiviral Drugs in the Eradication of Polio: Workshop Report. National Academies Press, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!